To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DC47891 | T-2307 |
T-2307, an arylamidine, has antifungal activities in vitro and in vivo. T-2307 exhibits broad-spectrum activity against clinically significant pathogens, including Candida species (MIC range, 0.00025 to 0.0078 μg/ml), Cryptococcus neoformans (MIC range, 0.0039 to 0.0625 μg/ml), and Aspergillus species (MIC range, 0.0156 to 4 μg/mL) .
More description
|
|
| DC47890 | TAK1-IN-3 |
TAK1-IN-3 is a potent ATP-competitive TAK1 inhibitor.
More description
|
|
| DC47888 | Thalidomide-O-amido-C6-NH2 |
Thalidomide-O-amido-C6-NH2 (Cereblon Ligand-Linker Conjugates 11), a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and a linker, can be used in the synthesis of PROTACs.
More description
|
|
| DC47887 | Thalidomide-O-amido-CH2-PEG3-CH2-NH-Boc |
Thalidomide-O-amido-CH2-PEG3-CH2-NH-Boc is a synthesized E3 ligase ligand-linker conjugate. Thalidomide-O-amido-CH2-PEG3-CH2-NH-Boc incorporates the Thalidomide based cereblon ligand and a linker. Thalidomide-O-amido-CH2-PEG3-CH2-NH-Boc can be used for the synthesis of PROTAC BET degrader. (From patent WO2017180417A1 compound s7).
More description
|
|
| DC47885 | TLR4-IN-C34-C2-amide-C6-OH |
TLR4-IN-C34-C2-amide-C6-OH is a linker that incorporates TLR4 inhibitor TLR4-IN-C34. TLR4-IN-C34 inhibits TLR4 in enterocytes and macrophages, and reduces systemic inflammation in mouse models of endotoxemia and necrotizing enterocolitis.
More description
|
|
| DC47880 | trans-Urocanic acid |
trans-urocanic acid (trans-UCA), a natural epidermal constituent, inhibits human natural killer cell (NK) activity in vitro. trans-urocanic acid is active in regulating an immune function.
More description
|
|
| DC47879 | Tri(TLR4-IN-C34-C2-amide-C3-amide-PEG1)-amide-C3-COOH |
Tri(TLR4-IN-C34-C2-amide-C3-amide-PEG1)-amide-C3-COOH is a linker that incorporates TLR4 inhibitor TLR4-IN-C34. TLR4-IN-C34 inhibits TLR4 in enterocytes and macrophages, and reduces systemic inflammation in mouse models of endotoxemia and necrotizing enterocolitis.
More description
|
|
| DC47878 | Tri(TLR4-IN-C34-C2-amide-PEG1)-amide-C3-COOH |
Tri(TLR4-IN-C34-C2-amide-PEG1)-amide-C3-COOH is a linker that incorporates TLR4 inhibitor TLR4-IN-C34. TLR4-IN-C34 inhibits TLR4 in enterocytes and macrophages, and reduces systemic inflammation in mouse models of endotoxemia and necrotizing enterocolitis.
More description
|
|
| DC47876 | TRPM8 antagonist 3 |
TRPM8 antagonist 3 is a novel TRPM8 blocker with an IC50 value of 11 nM.
More description
|
|
| DC47875 | Ulmoidol |
Ulmoidol prevents neuroinflammation by targeting the PU.1 transcriptional signaling pathway.
More description
|
|
| DC47874 | Vanillinbananin |
Vanillinbananin is an effective inhibitor of the ATPase activity of the SARS Coronavirus helicase with an IC50 value of 0.68 μM.
More description
|
|
| DC47873 | Vps34-IN-3 |
Vps34-IN-3 is a potent, selective, and orally bioavailable VPS34 kinase inhibitor.
More description
|
|
| DC47872 | WNK-IN-11-d3 |
WNK-IN-11 D3 is an orally active, selective and potent With-No-Lysine (WNK) kinase inhibitor. WNK-IN-11 D3 is effective at regulating cardiovascular homeostasis.
More description
|
|
| DC47871 | XIAP degrader-1 |
XIAP degrader-1, a primary amine tethered small molecule, promotes the degradation of X-linked inhibitor of apoptosis protein (XIAP).
More description
|
|
| DC47870 | XJB-5-131 |
XJB-5-131 is a mitochondria-targeted ROS and electron scavenger. XJB-5-131 is a bi-functional antioxidant that comprises a radical scavenger. XJB-5-131 is a synthetic antioxidant that targets mitochondria. XJB-5-131 is an effective ionizing irradiation protector and mitigator of cord blood mononuclear cells (CB MNCs).
More description
|
|
| DC47869 | YB-0158 |
YB-0158 (Wnt pathway inhibitor 2) is a reverse-turn peptidomimetic and a potent colorectal cancer stem cell (CSC) targeting agent. YB-0158 disrupts Sam68-Src interactions and induces apoptosis in CRC cells. Anti-cancer activities.
More description
|
|
| DC47868 | Zeteletinib hemiadipate |
Zeteletinib (BOS-172738; DS-5010) hemiadipate is an orally active, selective RET kinase inhibitor with nanomolar potency against RET and >300-fold selectivity against VEGFR2. Zeteletinib hemiadipate shows exquisite potency for the wild type RET, RETV804M/L gatekeeper mutants, and the most common oncogenic RET mutation M918T. Zeteletinib hemiadipate has potent antitumor activity.
More description
|
|
| DC47867 | β-Damascone |
β-Damascone is an aroma active rice volatile and is widely used in perfume compositions. β-Damascone has also received certain attention as a potential cancer chemopreventive and a mosquito and muscoid insecticide.
More description
|
|
| DC47866 | β-Lactamase-IN-6 |
β-Lactamase-IN-6 is a β-Lactamase inhibitor that shows high antibacetrial activity.
More description
|
|
| DC47865 | β-Rubromycin |
β-Rubromycin is a potent and selective inhibitor of human immunodeficiency virus-1 (HIV-1) RNA-directed DNA polymeras (reverse transcriptase). β-Rubromycin is a class of quinone antibacterials.
More description
|
|
| DC47864 | γ-Acetylenic GABA |
γ-Acetylenic GABA (4-Aminohex-5-ynoic acid) is an irreversible inhibitor of GABA-transaminase. γ-Acetylenic GABA can increase the concentration of GABA in rat brain.
More description
|
|
| DC22800 | ML-210 Featured |
A small-molecule probe that selectively kills cells induced to express mutant RAS.
More description
|
|
| DC22834 | Roseoflavin Featured |
Roseoflavin is a chemical analog of FMN and riboflavin that has antimicrobial activity.
More description
|
|
| DC22913 | WEB-2086 Featured |
A potent and specific antagonist of platelet activating factor (PAF) receptor that inhibits PAF-induced human platelet and neutrophil aggregation in vitro with IC50 of 0.17 and 0.36 uM, respectively.
More description
|
|
| DC11481 | AZD-0364 Featured |
AZD-0364 is a potent and selective ERK2 inhibitor extracted from patent WO2017080979A1, compound example 18, has an IC50 of 0.6 nM.
More description
|
|
| DC22989 | BMS-204493 Featured |
A pan-RAR inverse agonist that blocks RARα activity with IC50 of 114 nM.
More description
|
|
| DC36924 | NNMTi Featured |
NNMTi is a nicotinamide N-methyltransferase (NNMT) inhibitor that promotes myoblast differentiation.
More description
|
|
| DC23191 | ZL-006 Featured |
ZL-006 (ZL 006, ZL006) is a brain penetrant small molecule inhibitor of PSD-95/nNOS interaction that prevents glutamate-induced excitotoxicity and cerebral ischemic damage in vivo.
More description
|
|
| DC23195 | CBR-5884 Featured |
A potent, selective, noncompetitive inhibitor of 3-phosphoglycerate dehydrogenase (PHGDH) with IC50 of 7 uM.
More description
|
|
| DC23211 | SKF 82958 Featured |
A potent, full dopamine D1 agonist.
More description
|
|